A
Aura Biosciences D
D
AURA
5.88000
USD
-0.07
(-1.18%)
مغلق
حجم التداول
6,649
الربح لكل سهم
-2
العائد الربحي
-
P/E
-3
حجم السوق
364,585,419
العنوان: Aura Biosciences
القطاع: Healthcare
الصناعة: Biotechnology
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.